Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Bromodomain and Extraterminal domain protein family comprises highly conserved nuclear regulators that interpret histone acetylation marks via tandem bromodomains while using their ET domains for diverse protein-protein interactions crucial for controlling gene expression programs across health and disease contexts. They play a central role in gene transcription, chromatin remodeling, and cellular processes such as proliferation, differentiation, and response to viral infection.
Inhibition of bromodomain-acetyllysine interactions
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bromodomain and Extraterminal Domain (BET) Proteins (BET).